USFDA gives nod to Alembic for generic drug to treat Parkinson’s disease

It is therapeutically equivalent to the reference listed drug product (RLD) Comtan tablets, 200 mg, of Orion Corporation.

261
USFDA Approval
USFDA Approval

Last Updated on October 14, 2024 by The Health Master

Alembic Pharmaceuticals on Thursday said it has received final approval from the US health regulator for its generic Entacapone tablets indicated for patients with Parkinson’s disease.

The approval by the US Food & Drug Administration (USFDA) for the abbreviated new drug application (ANDA) for Entacapone tablets is for a strength of 200 mg, the company said in a regulatory filing.

It is therapeutically equivalent to the reference listed drug product (RLD) Comtan tablets, 200 mg, of Orion Corporation.

Entacapone tablets are indicated as an adjunct to other medications, levodopa and carbidopa, to treat end-of-dose “wearing off” in patients with Parkinson’s disease.

Citing IQVIA data, Alembic said Entacapone tablets 200 mg have an estimated market size of USD 10.5 million for the 12 months ended September 2021.

In the ongoing fiscal year so far, the company said it has received 17 approvals (13 final approvals and 4 tentative approvals) and a cumulative total of 156 ANDA approvals (136 final approvals and 20 tentative approvals) from the USFDA.

USFDA gives nod to Alembic Pharma for Doxycycline Hyclate tablets

USFDA gives tentative nod to Zydus Cadila for Pimavanserin capsules

USFDA gives tentative nod to Amphastar Pharma for Vasopressin injection

USFDA gives nod to Granules India for Prazosin HCL capsules

USFDA gives nod to Lupin for this drug to treat Kidney disease

USFDA gives nod to Lupin generic Azilsartan Medoxomil tablets

No Paracetamol, Painkillers recommended after Covaxin jab

Govt is expected to amend New Drugs and Clinical Trial Rules 2019

Chemists told to stock up on key medicines

Dr Reddy’s to launch anti-Covid drug Molnupiravir at Rs 35 per…

Govt to allow parallel submission of these applications for New Drugs

USFDA gives nod to Alembic Pharma for Doxycycline Hyclate tablets

DCGI directs all State Drugs Controllers to implement ONDLS portal

DTAB recommends Bar code on top 300 brands of drug products

Pharma Firm booked for Rs 1,627 Crore Loan Fraud

Latest Notifications regarding Pharmaceuticals

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

YouTube Icon

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos on consumer awareness, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news